Registration - Consultant

Eli Lilly Canada Inc. / ANDRE ALBINATI, Consultant

Registration Information

Client name: Eli Lilly Canada Inc.
Lobbyist name: ANDRE ALBINATI, Consultant
Initial registration start date: 2012-01-30
Registration status: Active
Registration Number: 775866-289825

Associated Communications

Total Number of Communication Reports: 5

Monthly communication reports in the last 6 months: 0

Version 15 of 16 (2024-04-26 to 2024-10-30)

Registration versions:

Version 15 of 16 (2024-04-26 to 2024-10-30)

Lobbying Information

Subject Matter Details

Details Regarding the Identified Subject Matter
Subject matters	Details	Categories
Federal-Provincial Relations, Health, Research and Development	Bill C-64, An Act respecting pharmacare (Pharmacare Act)	Legislative Proposal, Bill or Resolution
Health, Research and Development, Science and Technology	Food and Drug Act - An Act respecting food, drugs, cosmetics and therapeutic devices. Discussions relating to progressive licensing and the modernization of the Food & Drug Act.	Legislative Proposal, Bill or Resolution
International Trade	Free trade treaty agreement as it relates to the Canada US Free Trade Agreement (CUSMA) and free trade negotiations as it relates to Columbia, India, and the European Union.	Policies or Program
Health, Intellectual Property	Intellectual Property - Changes to Patented Medicine (Notice of Compliance) (PMNOC) regulations - important regulations that can affect Eli Lilly's business.	Regulation
Health, Intellectual Property, Science and Technology	Patent Act - An Act respecting patents of invention with regard to Intellectual Property Protection for pharmaceutical products - federal court decisions that have changed the disclosure requirements regarding the utility of an invention.	Legislative Proposal, Bill or Resolution
Health, Industry, Intellectual Property	Patented Medicine Notice of Compliance (PMNOC) Regulations - enforcement of Intellectual Property with respect to the Canadian pharmaceutical industry.	Regulation
Industry, Intellectual Property, Taxation and Finance	Patented Medicines Prices Review Board (PMPRB) proposed regulations, in regards to pharmaceutical pricing policy.	Policies or Program
Health, Science and Technology	The government's Science and Technology Strategy potential policies & programs pertaining to the biopharmaceutical industry.	Policies or Program

Communication Techniques

Written communication
Oral communication

The lobbyist has arranged or expects to arrange one or more meetings on behalf of the client between a public office holder and any other person in the course of this undertaking.

Government Institutions

Federal Economic Development Agency for Southern Ontario (FedDev)
Finance Canada (FIN)
Global Affairs Canada (GAC)
Health Canada (HC)
House of Commons
Indigenous Services Canada (ISC)
Innovation, Science and Economic Development Canada (ISED)
Patented Medicine Prices Review Board (PMPRB)
Prime Minister's Office (PMO)
Privy Council Office (PCO)
Senate of Canada

Client Details

Government funding

No government funding was received during the last completed financial year.

Client Contact Information

Address:
P. O. Box 73, Exchange Tower 130 King Street West, Suite 900 Toronto, ON Canada
Toronto, ON M5X 1B1
Canada

Telephone number: 416-699-7222

Client representative

Jill Daley, General Counsel and Vice President, Corporate Affairs

Parent Company Information

Eli Lilly & Company
- Lilly Corporate Center
  Indianapolis, IN 46225
  United States of America

Coalition Members Information

Eli Lilly Canada Inc. is not a coalition.

Individual, organization or corporation with a Direct Interest Beneficiary Information

The activities of Eli Lilly Canada Inc. are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.

Subsidiary Beneficiary Information

BIOTECCANADA (Partner)
- 420-130 Albert Street
  Ottawa, ON K1P 5G4
  Canada
Innovative Medicines Canada (Partner)
- 55 Metcalfe Street
  Ottawa, ON K1P 6L5
  Canada

Lobbyist Details

ANDRE ALBINATI | Public offices held

Business address:
Suite 200, 46 Elgin Street
OTTAWA, ON K1P 5K6
Canada

Telephone number: 613-563-4455
Fax number: 613-236-6173

Consultant Firm and Address

Firm: Earnscliffe Strategy Group

Address:
Suite 200, 46 Elgin Street
OTTAWA, ON K1P 5K6
Canada

Telephone number: 613-563-4455
Fax number: 613-236-6173

Eli Lilly Canada Inc.

The following names have been used on or after July 2, 2008

The following names have been used on or after July 2, 2008
Name	From	To
Eli Lilly Canada Inc.	2024-04-26	current
Eli Lilly Canada Inc.	2012-01-30	2024-04-26

Eli Lilly Canada Inc.

Responsible Officer History
Responsible Officer Name	From (YYYY-MM-DD)	To (YYYY-MM-DD)

List of Public Offices Held
Position	Period Held	Last Date Designated Public Office Held
Multilateral Trade Policy Advisor to the Minister International Trade, Office of the Minister	September 1999 to April 2002	Not a designated office
Senior Policy Advisor to the Minister Human Resources Development Canada, Office of the Minister	August 1998 to August 1999	Not a designated office
Policy Advisor to the Minister Human Resources Development Canada, Office of the Minister	October 1996 to August 1998	Not a designated office
Policy Advisor to the Minister International Cooperation and Responsible for La Francophonie, Office of the Minister	April 1996 to October 1996	Not a designated office

List of Public Offices Held
Position	Period Held	Last Date Designated Public Office Held
Multilateral Trade Policy Advisor to the Minister International Trade, Office of the Minister	September 1999 to April 2002	Not a designated office
Senior Policy Advisor to the Minister Human Resources Development Canada, Office of the Minister	August 1998 to August 1999	Not a designated office
Policy Advisor to the Minister Human Resources Development Canada, Office of the Minister	October 1996 to August 1998	Not a designated office
Policy Advisor to the Minister International Cooperation and Responsible for La Francophonie, Office of the Minister	April 1996 to October 1996	Not a designated office

Date Modified:: 2024-11-13

Search and menus

Language selection

Registration - Consultant

Eli Lilly Canada Inc. / ANDRE ALBINATI, Consultant

Registration Information

Associated Communications

Version 15 of 16 (2024-04-26 to 2024-10-30)

Version 15 of 16 (2024-04-26 to 2024-10-30)

Subject Matter Details

Communication Techniques

Government Institutions

Government funding

Client Contact Information

Client representative

Parent Company Information

Coalition Members Information

Individual, organization or corporation with a Direct Interest Beneficiary Information

Subsidiary Beneficiary Information

Consultant Firm and Address